← 返回

肥胖相关癌症中的大网膜:阻碍 NK 细胞有效迁移至肿瘤,可经 CX3CR1 拮抗克服

英文原题:The Omentum in Obesity-Associated Cancer: A Hindrance to Effective Natural Killer Cell Migration towards Tumour Which Can Be Overcome by CX3CR1 Antagonism.

查看英文原题

The Omentum in Obesity-Associated Cancer: A Hindrance to Effective Natural Killer Cell Migration towards Tumour Which Can Be Overcome by CX3CR1 Antagonism.

PubMed 2021/12/23(内容时间) Cancers (Basel) Q2 · IF 4.8(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

食管胃腺癌(OAC)与肥胖相关,其发生发展伴有严重免疫失调。我们此前发现,自然杀伤(NK)细胞优先迁移至OAC患者的网膜,在此发生表型和功能改变并出现凋亡;同时确认CX3CR1-趋化因子CX3CL1(fractalkine)通路对NK细胞募集至网膜至关重要。

本研究进一步探讨暴露于OAC网膜的可溶性微环境,尤其是fractalkine和IL-15,是否会影响NK细胞向食管肿瘤归巢。

结果显示,暴露于网膜脂肪组织条件培养液(ACM)后,NK细胞向OAC肿瘤组织条件培养液(TCM)的迁移减少;CX3CR1拮抗剂E6130能够恢复这种迁移。

此外,单独使用fractalkine或将其与IL-15联用,对NK细胞向TCM迁移的影响相反;fractalkine还会抑制IL-15介导的死亡受体配体表达上调。有趣的是,尽管fractalkine和/或IL-15会改变整合素α4β7的表达,却未显著影响NK细胞对黏膜地址素细胞黏附分子1(MAdCAM-1)的黏附。

本研究进一步支持CX3CR1拮抗在OAC中的治疗潜力:它可能使NK细胞免受网膜和fractalkine的不利影响,从而限制NK细胞功能障碍。

展开英文摘要原文

Oesophagogastric adenocarcinomas (OAC) are obesity-associated malignancies, underpinned by severe immune dysregulation.

We have previously shown that natural killer (NK) cells preferentially migrate to OAC omentum, where they undergo phenotypic and functional alterations and apoptosis.

Furthermore, we have identified the CX3CR1:fractalkine (CX3CL1) pathway as pivotal in their recruitment to omentum.

Here, we elucidate whether exposure to the soluble microenvironment of OAC omentum, and in particular fractalkine and IL-15 affects NK cell homing capacity towards oesophageal tumour.

Our data uncover diminished NK cell migration towards OAC tumour tissue conditioned media (TCM) following exposure to omental adipose tissue conditioned media (ACM) and reveal that this migration can be rescued with CX3CR1 antagonist E6130.

Furthermore, we show that fractalkine has opposing effects on NK cell migration towards TCM, when used alone or in combination with IL-15 and uncover its inhibitory effects on IL-15-mediated stimulation of death receptor ligand expression. Interestingly, treatment with fractalkine and/or IL-15 do not significantly affect NK cell adhesion to MAdCAM-1, despite changes they elicit to the expression of integrin 4 7.

This study provides further evidence that CX3CR1 antagonism has therapeutic utility in rescuing NK cells from the deleterious effects of the omentum and fractalkine in OAC, thus limiting their dysfunction.

论文信息

作者
Mylod E、O'Connell F、Donlon NE、Butler C、Reynolds JV、Lysaght J、Conroy MJ
单位
Cancer Immunology and Immunotherapy Group, Department of Surgery, Trinity Translational Medicine Institute, Trinity College Dublin, St James's Hospital, Dublin 8, Ireland.Ireland
期刊
Cancers2021 Dec 23
原文标识
PubMed 35008227 · DOI 10.3390/cancers14010064